Coronary disease & ACS

Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease

JAMA CardiolPublished Preplanned subgroup analysis of the STOP-CP prospective multisite cohort study

Authors' conclusion

Among patients with known CAD, the ESC 0/1-hour hs-cTnT algorithm was unable to safely exclude 30-day cardiac death or MI.

Study context

Population
ED patients ≥21 years with symptoms suggestive of ACS without ST-segment elevation on initial ECG, 8 US EDs, 2017–2018
Participants
1,430 patients
Comparison
European Society of Cardiology (ESC) 0/1-hour high-sensitivity cardiac troponin T (hs-cTnT) algorithm performance in patients with vs without known coronary artery disease (CAD)
  • Known CADn = 449
  • Without CADn = 981reference
Primary endpoint
Cardiac death or MI determined by expert adjudicators
Follow-up
30 days
Methodological detailsmulticentre, 8 US EDs, diagnostic accuracy
  • Multicentre
  • 8 US EDs
  • Diagnostic accuracy

Primary result

As reported in the abstract

30-day cardiac death or MI in rule-out zone; NPV
GroupValueRuled outNPV
Known CAD3.4%178 of 449 (39.6%)96.6% (95% CI, 92.8-98.8)
Without CAD1.1%648 of 981 (66.1%)98.9% (95% CI, 97.8-99.6)

Value

Known CAD3.4%
Without CAD1.1%

Ruled out

Known CAD178 of 449 (39.6%)
Without CAD648 of 981 (66.1%)

NPV

Known CAD96.6% (95% CI, 92.8-98.8)
Without CAD98.9% (95% CI, 97.8-99.6)
  • Known CAD vs Without CAD: P < 0.001 — proportion ruled out
  • Known CAD vs Without CAD: P < 0.001 — 30-day cardiac death or MI in rule-out zone
  • Known CAD vs Without CAD: P = 0.04 — NPV

Further findings

30-day cardiac death or MI, whole cohort

Cardiac death or MI
183 participants (12.8%)

Original publication

Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease. JAMA Cardiol. Published 1 April 2023. doi:10.1001/jamacardio.2023.0031

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.